Albert Martín‐Cardona

Author

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas ORCID

Also Known As

A Martin, A Martin Cardona, A Martin-Cardona, A Martín-Cardona, A Martín‐Cardona, A. Martin, A. Martin-Cardona, A. Martín-Cardona, A. Martín‐Cardona, A.M. Cardona

Publications

923

Citations

H-Index

Concepts

All Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Mútua Terrassa Universitat de Barcelona Bellvitge University Hospital Hospital Universitario Río Hortega

About

Albert Martín‐Cardona is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in pathogenesis, virology, and sequencing.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	45
2	Pathology	1	1	45
3	Pathogenesis	1	1	45
4	Viral Hepatitis	1	1	45
5	Hepatitis	1	1	45

Albert Martín‐Cardona

Publications

828

Citations

H-Index

Page 1

	Year	Citations
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease Alba Garrido-Trigo, A M Corraliza, Marisol Veny, Nature Communications	2023	233
Training Physicians in Counseling about Smoking Cessation Steven R. Cummings, Thomas J. Coates, Robert J. Richard, Annals of Internal Medicine	1989	201
Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry María Chaparro, Ana Garre, Elena Ricart, Alimentary Pharmacology & Therapeutics	2018	95
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2019	70
Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2020	65
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure Qian Chen, Celia Perales, María Eugenia Soria, Antiviral Research Viral HepatitisMedicinePathogenesisNext-generation SequencingPathology	2019	45
Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study María José Casanova, María Chaparro, Óscar Nantes, Alimentary Pharmacology & Therapeutics	2021	22
SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports Albert Martín‐Cardona, Josep Lloreta, Raquel Albero‐González, BMC Gastroenterology	2021	19
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu María José García, Montserrat Rivero, José Miranda-Bautista, Journal of Clinical Medicine	2021	18
EUS-guided tissue acquisition in the study of the adrenal glands: Results of a nationwide multicenter study Albert Martín‐Cardona, Glòria Fernández‐Esparrach, João Subtil, PLoS ONE	2019	16

Page 1